Literature DB >> 15623478

Association of specific genotype and haplotype of p53 gene with cervical cancer in India.

S Mitra1, C Misra, R K Singh, C K Panda, S Roychoudhury.   

Abstract

BACKGROUND: The predictive value of codon 72 arginine homozygosity at the p53 gene for human papilloma virus associated cervical cancer risk remains inconclusive. It has also been proposed that the inheritance of specific germline haplotypes based on three biallelic polymorphisms of p53 (intron 3 16 bp duplication, codon 72 Bst UI (Arg/Pro), and intron 6 Nci I restriction fragment length polymorphism at nucleotide 13494) is a better predictor of various cancer risks. AIMS: To determine the genotype and haplotype frequency of these three p53 polymorphisms in 61 patients with cervical squamous cell carcinoma and 94 ethnically matched controls from the eastern region of India and estimate the risk, if any, of specific genotypes and haplotypes.
METHODS: Samples were genotyped by polymerase chain reaction followed by variant specific restriction enzyme digestion. Haplotypes were estimated by the maximum likelihood method using the expectation maximisation algorithm.
RESULTS: Genotype distributions of the three polymorphisms in patients and controls showed a good fit to the Hardy-Weinberg equilibrium. The p53 codon 72 arginine homozygous genotype was significantly over represented in patients compared with controls. Those with the homozygous arginine genotype exhibited a 2.59 fold higher risk of developing squamous cell carcinoma of the uterine cervix. A significant risk was also seen with a combination of two haplotypes, 1-2-1 and 1-2-2.
CONCLUSION: p53 codon 72 arginine homozygotes appear to be at greater risk of developing squamous cell carcinoma of the uterine cervix. The high risk haplotypes 1-2-1 and 1-2-2 also contain the arginine allele, further strengthening this conclusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15623478      PMCID: PMC1770549          DOI: 10.1136/jcp.2004.019315

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  66 in total

1.  p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women.

Authors:  T Agorastos; A F Lambropoulos; T C Constantinidis; A Kotsis; J N Bontis
Journal:  Eur J Cancer Prev       Date:  2000-04       Impact factor: 2.497

2.  Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand.

Authors:  Wannapa Settheetham-Ishida; Yuwanee Singto; Pissamai Yuenyao; Wichittra Tassaneeyakul; Nipa Kanjanavirojkul; Takafumi Ishida
Journal:  Cancer Lett       Date:  2004-07-16       Impact factor: 8.679

Review 3.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

4.  Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.

Authors:  M van Duin; P J Snijders; M T Vossen; E Klaassen; F Voorhorst; R H Verheijen; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

5.  Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

Authors:  A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

6.  Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections.

Authors:  P Balaram; K R Nalinakumari; E Abraham; A Balan; N K Hareendran; H U Bernard; S Y Chan
Journal:  Int J Cancer       Date:  1995-05-16       Impact factor: 7.396

Review 7.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

8.  P53 germ line haplotypes associated with increased risk for colorectal cancer.

Authors:  A Själander; R Birgander; L Athlin; R Stenling; J Rutegård; L Beckman; G Beckman
Journal:  Carcinogenesis       Date:  1995-07       Impact factor: 4.944

9.  p53 polymorphisms and haplotypes in breast cancer.

Authors:  A Själander; R Birgander; G Hallmans; S Cajander; P Lenner; L Athlin; G Beckman; L Beckman
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

Review 10.  p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review.

Authors:  Anita Koushik; Robert W Platt; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

View more
  18 in total

1.  Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.

Authors:  Meenakshi Umar; Rohit Upadhyay; Rohini Khurana; Shaleen Kumar; Uday Chand Ghoshal; Balraj Mittal
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

Review 2.  Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.

Authors:  Mukesh Verma; Daniela Seminara; Fernando J Arena; Christy John; Kumiko Iwamoto; Virginia Hartmuller
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.

Authors:  Tatiana Dantas Rodrigues Laprano; Erika Hardy Lemos; Lia Moreira Pinto Cunha; José Eleutério Júnior; Rosiane Alves de SousaTeles; Silvia Helena Barem Rabenhorst
Journal:  Tumour Biol       Date:  2014-04-30

4.  The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.

Authors:  Samira Zoa Assoumou; Anicet Luc M Boumba; Angelique Ndjoyi-Mbiguino; Abdelkrim Khattabi; Moulay Mustapha Ennaji
Journal:  Med Oncol       Date:  2014-12-12       Impact factor: 3.064

5.  Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.

Authors:  S Mitra; S Banerjee; C Misra; R K Singh; A Roy; A Sengupta; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

6.  p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.

Authors:  M Meftah El khair; M M Ennaji; R El kebbaj; R Ait Mhand; M Attaleb; M El Mzibri
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

7.  Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.

Authors:  Faith Pangilinan; Kerry Geiler; Jessica Dolle; James Troendle; Deborah A Swanson; Anne M Molloy; Marie Sutton; Mary Conley; Peadar N Kirke; John M Scott; James L Mills; Lawrence C Brody
Journal:  Am J Med Genet A       Date:  2008-10-15       Impact factor: 2.802

Review 8.  Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.

Authors:  Cara M Martin; Louise Kehoe; Cathy O Spillane; John J O'Leary
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay.

Authors:  C E Lange; K Tobler; C Favrot; M Müller; J O Nöthling; M Ackermann
Journal:  Clin Vaccine Immunol       Date:  2008-11-26

10.  Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients.

Authors:  P Yadav; M Masroor; K Tanwer; R Mir; J Javid; I Ahmad; M Zuberi; R C M Kaza; S K Jain; N Khurana; P C Ray; A Saxena
Journal:  Clin Transl Oncol       Date:  2015-11-09       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.